DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population

Clinical Epigenetics

Volumn 5, Issue 1, 2013, Pages

  Kullmann, Kathrin ^a   Deryal, Mustafa ^a   Ong, Mei Fang ^a   Schmidt, Werner ^a   Mahlknecht, Ulrich ^a,b  

^a SAARLAND UNIVERSITY   (Germany)

^b St Lukas Hospital   (Germany)

Author keywords

Breast cancer; DNMT; SNP

Indexed keywords

DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; COMPARATIVE STUDY; COMPUTER MODEL; CONTROLLED STUDY; CPG ISLAND; DNMT1 GENE; DNMT3A GENE; DNMT3B GENE; EUROPE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; GENOTYPE; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; VERY ELDERLY; YOUNG ADULT;

EID: 84887149481     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/1868-7083-5-7     Document Type: Article

References (36)

1. McPherson K, Steel CM, Dixon JM: ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 2000, 321(7261):624-628.
2. Cebrian A, Pharoah PD, Ahmed S, Ropero S, Fraga MF, Smith PL, Conroy D, Luben R, Perkins B, Easton DF, Dunning AM, Esteller M, Ponder BA: Genetic variants in epigenetic genes and breast cancer risk. Carcinogenesis 2006, 27(8):1661-1669. (Pubitemid 44303919)
3. Turek-Plewa J, Jagodzinski PP: The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett 2005, 10(4):631-647. (Pubitemid 43161688)
4. Ehrlich M: DNA methylation in cancer: too much, but also too little. Oncogene 2002, 21(35):5400-5413.
5. Ting AH, McGarvey KM, Baylin SB: The cancer epigenome-components and functional correlates. Genes Dev 2006, 20(23):3215-3231.
6. Baylin SB, Belinsky SA, Herman JG: Aberrant methylation of gene promoters in cancer - concepts, misconcepts, and promise. J Natl Cancer Inst 2000, 92(18):1460-1461.
7. Das PM, Singal R: DNA methylation and cancer. J Clin Oncol 2004, 22(22):4632-4642. (Pubitemid 41185132)
8. Girault I, Tozlu S, Lidereau R, Bièche I: Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin Cancer Res 2003, 9(12):4415-4422. (Pubitemid 37248399)
9. Giacinti L, Claudio PP, Lopez M, Giordano A: Epigenetic information and estrogen receptor alpha expression in breast cancer. Oncologist 2006, 11(1):1-8. (Pubitemid 43152681)
10. Yen RW, Vertino PM, Nelkin BD, Yu JJ, el-Deiry W, Cumaraswamy A, Lennon GG, Trask BJ, Celano P, Baylin SB: Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic Acids Res 1992, 20(9):2287-2291.
11. Bestor TH: The DNA methyltransferases of mammals. Hum Mol Genet 2000, 9(16):2395-2402.
12. Miremadi A, Oestergaard MZ, Pharoah PD, Caldas C: Cancer genetics of epigenetic genes. Hum Mol Genet 2007, 16(Spec No 1):R28-R49. (Pubitemid 47241841)
13. Bestor T, Laudano A, Mattaliano R, Ingram V: Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol 1988, 203(4):971-983.
14. Saito Y, Kanai Y, Nakagawa T, Sakamoto M, Saito H, Ishii H, Hirohashi S: Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer 2003, 105(4):527-532. (Pubitemid 36578558)
15. Robertson KD: DNA methylation, methyltransferases, and cancer. Oncogene 2001, 20(24):3139-3155.
16. Veeck J, Esteller M: Breast cancer epigenetics: from DNA methylation to microRNAs. J Mammary Gland Biol Neoplasia 2010, 15(1):5-17.
17. Lavoie G, Estève PO, Laulan NB, Pradhan S, St-Pierre Y: PKC isoforms interact with and phosphorylate DNMT1. BMC Biol 2011, 9(1):31.
18. Goll MG, Bestor TH: Eukaryotic cytosine methyltransferases. Annu Rev Biochem 2005, 74:481-514. (Pubitemid 40995515)
19. Bachman KE, Rountree MR, Baylin SB: Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J Biol Chem 2001, 276(34):32282-32287.
20. Ramsahoye BH, Biniszkiewicz D, Lyko F, Clark V, Bird AP, Jaenisch R: Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci USA 2000, 97(10):5237- 5242.
21. Goll MG, Kirpekar F, Maggert KA, Yoder JA, Hsieh CL, Zhang X, Golic KG, Jacobsen SE, Bestor TH: Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science 2006, 311(5759):395-398. (Pubitemid 43132667)
22. Jurkowski TP, Meusburger M, Phalke S, Helm M, Nellen W, Reuter G, Jeltsch A: Human DNMT2 methylates tRNA(Asp) molecules using a DNA methyltransferase- like catalytic mechanism. RNA 2008, 14(8):1663-1670.
23. Sun MY, Yang XX, Xu WW, Yao GY, Pan HZ, Li M: Association of DNMT1 and DNMT3B polymorphisms with breast cancer risk in Han Chinese women from South China. Genet Mol Res 2012, 11(4):4330-4341.
24. Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, Benítez J, Arias Pérez JI, Zamora MP, Malats N, Dos Santos SI, Gibson LJ, Fletcher O, Johnson N, Anton-Culver H, Ziogas A, Figueroa J, Brinton L, Sherman ME, Lissowska J, Hopper JL, Dite GS, Apicella C, Southey MC, Sigurdson AJ, Linet MS, Schonfeld SJ, Freedman DM, Mannermaa A, Kosma VM, Kataja V, et al: Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res 2010, 12(6):R110.
25. Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U, Schmidt M, Häberle L, Vrieling A, Gaudet M, Figueroa J, Schoof N, Spurdle AB, Rudolph A, Fasching PA, Hopper JL, Makalic E, Schmidt DF, Southey MC, Beckmann MW, Ekici AB, Fletcher O, Gibson L, Dos Santos SI, Peto J, Humphreys MK, Wang J, Cordina-Duverger E, Menegaux F, et al: Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet 2013, 9(3):e1003284.
26. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, Kandoth C, Payton JE, Baty J, Welch J, Harris CC, Lichti CF, Townsend RR, Fulton RS, Dooling DJ, Koboldt DC, Schmidt H, Zhang Q, Osborne JR, Lin L, O'Laughlin M, McMichael JF, Delehaunty KD, McGrath SD, Fulton LA, Magrini VJ, Vickery TL, Hundal J, Cook LL, Conyers JJ, et al: DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010, 363(25):2424-2433.
27. Walter MJ, Ding L, Shen D, Shao J, Grillot M, McLellan M, Fulton R, Schmidt H, Kalicki-Veizer J, O'Laughlin M, Kandoth C, Baty J, Westervelt P, DiPersio JF, Mardis ER, Wilson RK, Ley TJ, Graubert TA: Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 2011, 25(7):1153-1158.
28. Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H: Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 2001, 97(5):1172-1179. (Pubitemid 32183737)
29. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA: The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999, 27(11):2291-2298. (Pubitemid 29245646)
30. Butcher DT, Rodenhiser DI: Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours. Eur J Cancer 2007, 43(1):210-219. (Pubitemid 46070215)
31. Roll JD, Rivenbark AG, Jones WD, Coleman WB: DNMT3b over-expression contributes to a hypermethylator phenotype in human breast cancer cell lines. Mol Cancer 2008, 7:15.
32. Shen H, Wang L, Spitz MR, Hong WK, Mao L, Wei Q: A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res 2002, 62(17):4992-4995. (Pubitemid 34984424)
33. Lee SJ, Jeon HS, Jang JS, Park SH, Lee GY, Lee BH, Kim CH, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Cho YL, Jung TH, Park JY: DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 2005, 26(2):403-409. (Pubitemid 40246562)
34. Montgomery KG, Liu MC, Eccles DM, Campbell IG: The DNMT3B C->T promoter polymorphism and risk of breast cancer in a British population: a case-control study. Breast Cancer Res 2004, 6(4):R390-R394.
35. Ye C, Beeghly-Fadiel A, Lu W, Long J, Shu XO, Gao YT, Zheng W, Cai Q: Two-stage case-control study of DNMT-1 and DNMT-3B gene variants and breast cancer risk. Breast Cancer Res Treat 2010, 121(3):765-769.
36. Xiang G, Zhenkun F, Shuang C, Jie Z, Hua Z, Wei J, Da P, Dianjun L: Association of DNMT1 gene polymorphisms in exons with sporadic infiltrating ductal breast carcinoma among Chinese Han women in the Heilongjiang Province. Clin Breast Cancer 2010, 10(5):373-377.